Patients should experience minimal or no gastrointestinal symptoms at their current dose, with resolution of initial nausea, vomiting, or diarrhea
SL, SM, Y-RL, HC, and E-JJ contributed to the conduct of the study and acquisition of data and analyzed and interpreted the data
To maximize the benefits of GLP-1s, it is recommended that you follow a healthy diet and engage in regular physical activity alongside your medication regiment
78 Acute pancreatitis is a rare but documented adverse event associated with exenatide use, as reported in the FDA Adverse Event Reporting System and observational studies
2 GLP-1 (glucagon-like peptide-1) lowers hunger, slows down how quickly the stomach empties, and helps the pancreas release insulin after a meal